Blog
LivaNova to Announce Third-Quarter 2023 Results
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, will host a conference call to discuss its third-quarter 2023 results on Wednesday, November 1, 2023 at 12 p.m. London time
ServiceNow Launches Now Assist for ITSM, CSM, HRSD, and Creator to Embed Generative AI Across All Workflows on the Now Platform
ServiceNow (NYSE: NOW), the leading digital workflow company making the world work better for everyone, today announced a major Now Platform expansion with the Now Assist family of solutions
AbCellera Expands Multi-Target Antibody Discovery Collaboration with Regeneron
AbCellera (Nasdaq: ABCL) announced today that it has expanded its existing multi-target collaboration with Regeneron (Nasdaq: REGN) to discover therapeutic antibodies for up to eight targets
Charles River Laboratories to Host Virtual Investor Day
Charles River Laboratories International, Inc. (NYSE: CRL) announced that it will host a virtual Meeting with Management on Thursday, September 21st, beginning at 8:30 a.m. ET.
This virtual
Redfin Survey: Most Respondents Support More Homebuilding, But Many Don’t Want a Complex in Their Neighborhood
(NASDAQ: RDFN) — Nearly four of every five (78%) respondents to a recent housing survey support policies that promote building more housing, according to a new report from Redfin (redfin.com), the
Freeport-McMoRan Declares Quarterly Cash Dividends on Common Stock
Freeport-McMoRan Inc. (NYSE: FCX) announced today that its Board of Directors declared cash dividends of $0.15 per share on FCX’s common stock payable on November 1, 2023, to shareholders of record
ICON Releases Expanded End-to-end Clinical Trial Tokenisation Solution
ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, today announces the release of its next generation Clinical Trial Tokenisation solution. The
Sunnova Announces Proposed Private Offering of $400 Million “Green Bond”
Sunnova Energy Corporation (“SEC”), a wholly-owned subsidiary of Sunnova Energy International Inc. (“Sunnova”), today announced that it intends to offer, subject to market conditions, $400 million
Carbon Streaming to Provide Microsoft With Biochar Carbon Removal
Carbon Streaming Corporation (NEO: NETZ) (OTCQB: OFSTF) (FSE: M2Q) (“Carbon Streaming” or the “Company”) is delighted to announce that it will provide Microsoft with carbon removal credits from the
Oceaneering Announces Private Offering of $200 Million of Senior Notes
Oceaneering International, Inc. (“Oceaneering”) (NYSE: OII) announced today that it intends to offer $200,000,000 aggregate principal amount of additional 6.000% Senior Notes due 2028 (the “2028
Xylem, Lorentz Partner to Accelerate Deployment of Solar-Powered Pumping Solutions
Xylem Inc. (NYSE: XYL), a leading global water technology company, and LORENTZ, the German solar water pump manufacturer, today announced they will enter into a distribution agreement to expand the
GE HealthCare Shares Key Focus Areas and Future Goals in its Inaugural Sustainability Report
GE HealthCare (Nasdaq: GEHC) today released its inaugural Sustainability Report, which describes the steps the Company has taken to establish its stand-alone environmental, social, and governance
Oceaneering Announces Cash Tender Offer for Any and All of its Outstanding 4.650% Senior Notes due 2024
Oceaneering International, Inc. (“Oceaneering”) (NYSE: OII) announced today that it has commenced a cash tender offer to purchase any and all of its outstanding 4.650% Senior Notes due 2024 (the
Supercuts® to Enter India Market Through Master Franchise Agreement
Regis Corporation (NYSE: RGS), a leader in the haircare industry, today announced that it is entering into a Master Franchise Agreement with Ravissant Style Private Limited, a corporate affiliate
Ault Alliance Issues Letter to Stockholders
Ault Alliance, Inc. (NYSE American: AULT), a diversified holding company (“Ault Alliance” or the “Company”), today provides a business update letter to its stockholders.
This press release
Elliptic Labs Shipping on HONOR V Purse Smartphone
Elliptic Labs (OSE: ELABS), a global AI software platform company and the world leader in AI Virtual Smart Sensors™ currently deployed in over 500 million devices, is announcing the launch of its
Exscientia Announces AI Drug Discovery Collaboration with Merck KGaA, Darmstadt, Germany
Exscientia plc (Nasdaq: EXAI) today announced a new collaboration with Merck KGaA, Darmstadt, Germany focused on the discovery of novel small molecule drug candidates across oncology
Sensorion Reports 2023 First Half Results
Regulatory News:
Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat, and prevent within
EPR Properties Publishes 2022 Corporate Responsibility Report
EPR Properties (NYSE:EPR) today announced that it published its 2022 Corporate Responsibility Report which covers its environmental, social and governance ("ESG") initiatives and progress. The
WisdomTree Announces Changes to ETF Registered Products
WisdomTree, Inc. (NYSE: WT), a global financial innovator, today announced plans to close and liquidate five WisdomTree ETFs.
The ETFs will no longer accept creation orders after Friday, October
Inter Parfums, Inc. Elects Kappauf to Its Board of Directors
Inter Parfums, Inc. (NASDAQ GS: IPAR) (“Interparfums” or the “Company”) today announced the election of Gerard Kappauf (“Kappauf”), to its board of directors, effective September 14, 2023. The
First Internet Bancorp to Pay Cash Dividend
The Board of Directors of First Internet Bancorp (the “Company”) (Nasdaq: INBK) has declared a quarterly cash dividend of $0.06 per common share. The dividend will be payable on October 16, 2023 to
Stevanato Group to Livestream Inaugural Capital Markets Day on September 27, 2023
Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, will
Xencor Appoints Barbara J. Klencke, M.D., to Board of Directors
Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies and cytokines for the treatment of cancer and autoimmune diseases, today announced the


